Seguir
Niklas Mattsson-Carlgren, MD, PhD
Niklas Mattsson-Carlgren, MD, PhD
Dirección de correo verificada de med.lu.se
Título
Citado por
Citado por
Año
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
Jama 302 (4), 385-393, 2009
13402009
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
12542015
Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease
N Mattsson, U Andreasson, H Zetterberg, K Blennow, ...
JAMA neurology 74 (5), 557-566, 2017
6242017
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
S Palmqvist, M Schöll, O Strandberg, N Mattsson, E Stomrud, H Zetterberg, ...
Nature communications 8 (1), 1214, 2017
5422017
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
S Janelidze, N Mattsson, S Palmqvist, R Smith, TG Beach, GE Serrano, ...
Nature medicine 26 (3), 379-386, 2020
5302020
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ...
The Lancet Neurology 19 (5), 422-433, 2020
5092020
Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders
S Palmqvist, S Janelidze, YT Quiroz, H Zetterberg, F Lopera, E Stomrud, ...
Jama 324 (8), 772-781, 2020
4992020
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...
The Lancet Neurology 16 (8), 661-676, 2017
4812017
Amyloid biomarkers in Alzheimer's disease
K Blennow, N Mattsson, M Schöll, O Hansson, H Zetterberg
Trends in pharmacological sciences 36 (5), 297-309, 2015
4702015
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
4032011
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
3862019
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
3842016
Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression
H Zetterberg, T Skillbäck, N Mattsson, JQ Trojanowski, E Portelius, ...
JAMA neurology 73 (1), 60-67, 2016
3742016
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
S Janelidze, H Zetterberg, N Mattsson, S Palmqvist, H Vanderstichele, ...
Annals of clinical and translational neurology 3 (3), 154-165, 2016
3612016
Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease
N Mattsson, NC Cullen, U Andreasson, H Zetterberg, K Blennow
JAMA neurology 76 (7), 791-799, 2019
3582019
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
3532013
Smoking and increased Alzheimer's disease risk: a review of potential mechanisms
TC Durazzo, N Mattsson, MW Weiner, ...
Alzheimer's & Dementia 10, S122-S145, 2014
3522014
Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder
O Hansson, S Janelidze, S Hall, N Magdalinou, AJ Lees, U Andreasson, ...
Neurology 88 (10), 930-937, 2017
3312017
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
S Palmqvist, N Mattsson, O Hansson, ...
Brain 139 (4), 1226-1236, 2016
2862016
The cerebrospinal fluid “Alzheimer profile”: easily said, but what does it mean?
FH Duits, CE Teunissen, FH Bouwman, PJ Visser, N Mattsson, ...
Alzheimer's & Dementia 10 (6), 713-723. e2, 2014
2832014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20